文献速递免疫规划慢病防控与筛查卫生政策与健康促进

高剂量流感疫苗对老年退伍军人死亡率的效果评估

High-dose influenza vaccination and mortality among predominantly male, white, senior veterans, United States, 2012/13 to 2014/15.
PubMed 文献 · Euro Surveill · 2020-01-01

本研究链接美国退伍军人健康管理局电子病历与医保数据,评估高剂量流感疫苗相比标准剂量在2012/13至2014/15流感季对65岁以上退伍军人流感/肺炎相关死亡和心肺死亡的保护效果。匹配分析显示,高剂量疫苗在高流感期与两类死亡率降低相关,但存在残余混杂。

要点

  • 高流感期高剂量疫苗对流感/肺炎相关死亡rVE为42%(95%CI:24-59)。
  • 高流感期高剂量疫苗对心肺死亡rVE为27%(95%CI:23-32)。
  • 排除基线高预测死亡率者后rVE仍显著,分别为36%和25%。

核心结论

  • 高剂量流感疫苗与老年男性退伍军人高流感期流感/肺炎相关死亡及心肺死亡风险降低相关。

研究设计与样本

  • 链接退伍军人健康管理局电子病历与医保行政文件,对2012/13至2014/15三个流感季65岁以上退伍军人进行匹配队列分析。
  • 共569552人季观察,其中高剂量疫苗接种者207574人季(36%),标准剂量361978人季(64%),以男性(99%)和白人(82%)为主。
  • 采用多变量Cox比例风险模型,按接种时间、地点、年龄、性别、种族和VHA优先级匹配。

主要发现

  • 高流感期高剂量对比标准剂量,流感/肺炎相关死亡调整rVE为42%(95%CI:24-59)。
  • 高流感期高剂量对比标准剂量,心肺死亡调整rVE为27%(95%CI:23-32)。
  • 排除基线1年预测死亡率高者后,流感/肺炎相关死亡rVE为36%(95%CI:10-62),心肺死亡rVE为25%(95%CI:12-38)。
  • 两阶段残差纳入法估计结果与上述一致。

临床怎么用

  • 在老年男性退伍军人群体中,高流感期选择高剂量流感疫苗可能进一步降低流感/肺炎相关及心肺死亡风险。
  • 临床决策需结合残余混杂可能性,个体化评估高龄或高死亡风险人群的接种策略。

局限性

  • 尽管匹配和多变量调整,早晚期流感时段均存在残余混杂。
  • 研究人群以男性(99%)和白人(82%)为主,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IntroductionIt is unclear whether high-dose influenza vaccine (HD) is more effective at reducing mortality among seniors.AimThis study aimed to evaluate the relative vaccine effectiveness (rVE) of HD. MethodsWe linked electronic medical record databases in the Veterans Health Administration (VHA) and Medicare administrative files to examine the rVE of HD vs standard-dose influenza vaccines (SD) in preventing influenza/pneumonia-associated and cardiorespiratory mortality among VHA-enrolled veterans 65 years or older during the 2012/13, 2013/14 and 2014/15 influenza seasons. A multivariable Cox proportional hazards model was performed on matched recipients of HD vs SD, based on vaccination time, location, age, sex, ethnicity and VHA priority level. ResultsAmong 569,552 person-seasons of observation, 207,574 (36%) were HD recipients and 361,978 (64%) were SD recipients, predominantly male (99%) and white (82%). Pooling findings from all three seasons, the adjusted rVE estimate of HD vs SD during the high influenza periods was 42% (95% confidence interval (CI): 24-59) against influenza/pneumonia-associated mortality and 27% (95% CI: 23-32) against cardiorespiratory mortality. Residual confounding was evident in both early and late influenza periods despite matching and multivariable adjustment. Excluding individuals with high 1-year predicted mortality at baseline reduced the residual confounding and yielded rVE of 36% (95% CI: 10-62) and 25% (95% CI: 12-38) against influenza/pneumonia-associated and cardiorespiratory mortality, respectively. These were confirmed by results from two-stage residual inclusion estimations.DiscussionThe HD was associated with a lower risk of influenza/pneumonia-associated and cardiorespiratory death in men during the high influenza period.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Young-Xu Y, Thornton Snider J, Mahmud SM, et al. High-dose influenza vaccination and mortality among predominantly male, white, senior veterans, United States, 2012/13 to 2014/15. Euro Surveill. 2020. PMID: 32431290. doi:10.2807/1560-7917.ES.2020.25.19.1900401

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。